Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT03552354

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03552354
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03552354. Allocation not applicable; no masking; primary purpose treatment. Start 2017-10-25 (actual); primary completion 2018-10-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
Condition
Stroke, Ischemic
Intervention (Drug)
Argatroban plus dual antiplatelet
Lead sponsor
General Hospital of Shenyang Military Region (class: other)

Record details

Record id
cardio:ct-nct03552354
Content hash
fc68388200e37ec7967dd6f531afe7b4a65e7dcdfa83bf49392f1201bd9dd820